# Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19

> **NCT04366271** · PHASE2 · WITHDRAWN · sponsor: **Hospital Infantil Universitario Niño Jesús, Madrid, Spain**

## Conditions studied

- COVID

## Interventions

- **BIOLOGICAL:** Mesenchymal cells
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT04366271
- **Lead sponsor:** Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-07
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2021-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04366271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04366271, "Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04366271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*